ARVO: Novel VEGF Inhibitor Helps in AMD
(MedPage Today) -- FORT LAUDERDALE, Fla. -- An investigational drug for treating "wet" age-related macular degeneration (AMD) was as effective as ranibizumab (Lucentis) even when dosed every other month, two identical one-year studies showed.